Benzinga | Jan 14, 2021 09:08AM EST

Roth Capital Maintains Buy on CryoPort, Raises Price Target to $72

Roth Capital analyst Richard Baldry maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $60 to $72.